Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of SYN006 HFA MDI vs Pulmicort and Meptin Air in Healthy Volunteers
NCT02165046Phase 1Completed
- Sponsor
- Intech Biopharm Corporation
- Start
- Feb 2012
- Primary completion
- Apr 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised trial of budesonide and procaterol in asthma and chronic obstructive pulmonary disease (COPD) (3 arms), sponsored by Intech Biopharm Corporation. Primary endpoints: Area Under Curve, Maximum plasma concentration and 1 more. Started Feb 2012; status: completed.
02
Drugs
budesonideprocaterol
03
Conditions
asthmachronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02165046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02165046.